HindustanTimes Sat,19 Apr 2014

Dr Reddy's Q3 profit jumps 70.21% to Rs. 618.42cr

PTI  New Delhi, February 11, 2014
First Published: 16:44 IST(11/2/2014) | Last Updated: 16:49 IST(11/2/2014)

Dr Reddy's Laboratories on Tuesday reported a 70.21% increase in its consolidated net profit at Rs. 618.42 crore for the third quarter ended December 31, 2013.


The company had posted a consolidated profit of Rs. 363.31 crore in the same period of the previous financial year.

Consolidated net sales rose to Rs. 3,533.76 crore in the quarter under review from Rs. 2,865.16 crore a year earlier, Dr Reddy's Laboratories said in a BSE filing.

Revenue from the global generics segment grew to Rs. 2,939.58 crore in the December quarter of 2013 as against Rs. 2,082.77 crore in the corresponding period a year ago, driven by North America, Russia and other emerging markets.

Shares of Dr Reddy's Laboratories were trading at Rs. 2668.15 per scrip during the afternoon trade at BSE, down 0.32% from its previous close.

more from Business

700 trainees opt for exit plan at Nokia’s Chennai plant

Finnish handset maker Nokia, struggling to shepherd its Chennai plant into its agreement to be bought by US software giant Microsoft amid tax disputes in India, has got some success with 736 of its trainees accepting the voluntary separation scheme.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved